glp-1 agonist therapy glp-1_analogs [TUSOM GLP-1 receptor agonists and acute

The FDA approval era: every major GLP-1 milestone (20052019) The decade and a half after Byetta produced the medications most patients now recognize

Novo Nordisk foundation, Boehringer Ingelheim

For more information, contact: Media: Kelsey Merkel [email protected] Investors: Corey Kinger [email protected] 1 Ahern, A

The American Association for the Study of Liver Diseases and the European Association for the Study of the Liver updated the terminology in 2023, renaming NAFLD as MASLD to better reflect the metabolic nature of the disease (Rinella et al., Hepatology 2023)

The following data were collected: publication year, country and continent, study setting (e.g., hospital, private practice, academic clinic), sample size, age range, mean age, study design, population characteristics, intervention details, outcomes, and effect measures (e.g., serum B12 levels)

References Ribreau-Gayon, P., Glories, Y., Maujean, A., & Dubourdieu, D